secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001213900-25-049491
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma accepts additional $670K in Reg S offering, issuing 957,144 shares
--------------------------------------------------------------------------------

- Initial Reg S offering (Apr 30–May 9) sold 1,030,413 shares for aggregate gross proceeds ~$619,625.
- On May 27, accepted additional subscriptions of $670,000 for 957,144 shares on same terms as initial offering.
- All shares sold to non-U.S. persons under Regulation S; voting rights transferred to chairman Eugene Jiang.
- Combined gross proceeds from both tranches total ~$1.29 million; shares unregistered for one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025049491/0001213900-25-049491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025049491/ea0243649-8ka_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-049491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer